Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 1;15(1):309.
doi: 10.1186/s13023-020-01590-7.

Maple syrup urine disease in Brazilian patients: variants and clinical phenotype heterogeneity

Affiliations

Maple syrup urine disease in Brazilian patients: variants and clinical phenotype heterogeneity

Ana Vitoria Barban Margutti et al. Orphanet J Rare Dis. .

Abstract

Background: Maple syrup urine disease (MSUD) is an autosomal recessive inherited metabolic disease caused by deficient activity of the branched-chain α-keto acid dehydrogenase (BCKD) enzymatic complex. BCKD is a mitochondrial complex encoded by BCKDHA, BCKDHB, DBT, and DLD genes. MSUD is predominantly caused by Variants in BCKDHA, BCKDHB, and DBT genes encoding the E1α, E1β, and E2 subunits of BCKD complex, respectively. The aim of this study was to characterize the genetic basis of MSUD by identifying the point variants in BCKDHA, BCKDHB, and DBT genes in a cohort of Brazilian MSUD patients and to describe their phenotypic heterogeneity. It is a descriptive cross-sectional study with 21 MSUD patients involving molecular genotyping by Sanger sequencing.

Results: Eight new variants predicted as pathogenic were found between 30 variants (damaging and non-damaging) identified in the 21 patients analyzed: one in the BCKDHA gene (p.Tyr120Ter); five in the BCKDHB gene (p.Gly131Val, p.Glu146Glnfs * 13, p.Phe149Cysfs * 9, p.Cys207Phe, and p.Lys211Asn); and two in the DBT gene (p.Glu148Ter and p.Glu417Val). Seventeen pathogenic variants were previously described and five variants showed no pathogenicity according to in silico analysis.

Conclusion: Given that most of the patients received late diagnoses, the study results do not allow us to state that the molecular features of MSUD variant phenotypes are predictive of clinical severity.

Keywords: Branched-chain amino acids; Inborn errors of metabolism; Isoleucine; Leucine; Maple syrup urine disease; Valine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Similar articles

Cited by

References

    1. Chuang DT, Shih VE, et al. Maple syrup urine disease. In: Scriver CR, et al., editors. The metabolic and molecular bases of inherited diseases. 8. New York: McGraw-Hill; 2001. pp. 1971–2005.
    1. Strauss KA, Carsona VJ, Soltys K, Young ME, Bowser LE, Puffenberger EG, Brigatti KW, Williams KB, Robinson DL, Hendrickson C, Beiler K, Morton DH. Branched-chain α-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes. Mol Genet Metab. 2020;129:193–206. doi: 10.1016/j.ymgme.2020.01.006. - DOI - PubMed
    1. Barschak AG, et al. Oxidative stress in plasma from maple syrup urine disease patients during treatment. Metab Brain Dis. 2008;23(1):711–780. doi: 10.1007/s11011-007-9077-y. - DOI - PubMed
    1. Barschak AG, et al. Maple syrup urine disease in treated patients: biochemical and oxidative stress profiles. Clin Biochem. 2008;41(4–5):317–324. doi: 10.1016/j.clinbiochem.2007.11.015. - DOI - PubMed
    1. Fisher CR, Fisher CW, Chuang DT, Cox RP. Occurrence of a Tyr393Asn (Y393N) mutation in the E1 alpha gene of the branched-chain alpha-keto acid dehydrogenase complex in maple syrup urine disease patients from a Mennonite population. Am J Hum Genet. 1991;49(2):429–434. - PMC - PubMed

Publication types

Substances